Surgery Partners (SGRY) Long-Term Investments (2014 - 2026)

Surgery Partners' Long-Term Investments history runs 13 years deep, the most recent figure standing at $225.4 million for Q1 2026.

• In Q1 2026, Long-Term Investments rose 3.11% year-over-year to $225.4 million; the TTM figure through Mar 2026 stood at $225.4 million (up 3.11% YoY), while the FY2025 annual figure was $234.0 million, up 8.64% from the prior year.
• Long-Term Investments came in at $225.4 million for Q1 2026 at Surgery Partners, down from $234.0 million in the prior quarter.
• In the past five years, Long-Term Investments ranged from a high of $234.0 million in Q4 2025 to a low of $94.5 million in Q1 2022.
• A 5-year average of $198.3 million and a median of $196.3 million in 2023 frame the typical range for Long-Term Investments.
• Across the five-year window, Long-Term Investments surged 114.54% in 2022 and dropped 3.26% in 2023, its largest moves.
• Surgery Partners' Long-Term Investments stood at $190.3 million in 2022, then retreated by 3.26% to $184.1 million in 2023, then increased by 17.0% to $215.4 million in 2024, then rose by 8.64% to $234.0 million in 2025, then retreated by 3.68% to $225.4 million in 2026.
• According to Business Quant data, Long-Term Investments over the past three periods registered $225.4 million, $234.0 million, and $229.4 million for Q1 2026, Q4 2025, and Q3 2025 respectively.

Peer Comparison